Johnson & Johnson (JNJ) analyst forecast and price target
Analyst forecast
Consensus of 27 analyst ratings
Based on 9 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| UBS | Maintained | Buy | $320.00 from $280.00 | Sep 2, 2026 |
| Guggenheim | Maintained | Buy | $287.00 from $270.00 | Aug 6, 2026 |
| Wells Fargo | Maintained | Overweight | $282.00 from $272.00 | Aug 3, 2026 |
| Guggenheim | Maintained | Buy | $270.00 | Jul 17, 2026 |
| Morgan Stanley | Maintained | Overweight | $294.00 from $284.00 | Jul 16, 2026 |
| Wells Fargo | Maintained | Overweight | $272.00 from $263.00 | Jul 16, 2026 |
| RBC Capital | Maintained | Outperform | $287.00 | Jul 16, 2026 |
| Raymond James | Maintained | Outperform | $265.00 from $258.00 | Jul 16, 2026 |
| RBC Capital | Maintained | Outperform | $287.00 from $265.00 | Jul 13, 2026 |
| TD Cowen | Maintained | Buy | $300.00 from $250.00 | Jul 13, 2026 |
| B of A Securities | Maintained | Neutral | $263.00 from $254.00 | Jul 10, 2026 |
| Citigroup | Maintained | Buy | $298.00 from $285.00 | Jul 8, 2026 |
| Morgan Stanley | Maintained | Overweight | $284.00 from $283.00 | Jul 8, 2026 |
| Guggenheim | Maintained | Buy | $270.00 from $266.00 | Jun 26, 2026 |
| Leerink Partners | Upgraded | Market Perform → Outperform | $265.00 | May 13, 2026 |
| Wells Fargo | Maintained | Overweight | $263.00 from $240.00 | Apr 15, 2026 |
| Stifel | Maintained | Hold | $250.00 from $220.00 | Apr 15, 2026 |
| Barclays | Maintained | Equal-Weight | $255.00 from $234.00 | Apr 15, 2026 |
| Morgan Stanley | Maintained | Overweight | $267.00 from $262.00 | Apr 10, 2026 |
| TD Cowen | Initiated Coverage | Buy | $250.00 | Apr 8, 2026 |
Frequently asked questions
What is the price target for JNJ stock?
The average 12-month analyst price target for Johnson & Johnson (JNJ) is $288.44, with a high estimate of $320.00 and a low of $263.00, across 9 analysts.
Is JNJ a buy, sell, or hold?
Analysts covering Johnson & Johnson currently average a Buy rating: 18 buy, 8 hold and 1 sell, from 27 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for JNJ?
The average price target of $288.44 implies 4.80% upside from the last price of $275.23.
What is the latest analyst rating on JNJ?
On Sep 2, 2026, UBS maintained Johnson & Johnson at Buy with a price target of $320.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.